Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald S Go

Showing results (141-150 of 402) with videos related to

Pageof 41
Sort By:
Haematologica|October 19, 2019
Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasmsGaurav Goyal, Aishwarya Ravindran, Yuanhang Liu, et al.
British Journal of Haematology|November 20, 2008
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsJames N George, Susan D Mathias, Ronald S Go, et al.
American Journal of Hematology|January 13, 2022
A population-based study of acute panmyelosis with myelofibrosis in the United States: 2004-2015Nicole McLaughlin, Gordon Ruan, Courtney N Day, et al.
The American Journal of Surgical Pathology|January 6, 2026
Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic InfiltratesAlma R Oskarsdottir, Aishwarya Ravindran, Matthew J Koster, et al.
Journal of Hematology & Oncology|July 9, 2013
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)Daniel R Greenwald, Hailun Li, Selina M Luger, et al.
JCO Oncology Practice|October 23, 2020
Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely RecommendationsUrshila Durani, Dennis Asante, Herbert C Heien, et al.
British Journal of Haematology|March 14, 2018
Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United StatesPriyanka A Pophali, Adam Bartley, Prashant Kapoor, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 30, 2023
Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et alMatthew J Koster, Umar Ghaffar, Tanaz A Kermani, et al.
Rheumatology (Oxford, England)|May 25, 2023
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndromeAlexander S Hines, Matthew J Koster, Allison R Bock, et al.
American Journal of Clinical Oncology|April 8, 2009
Publication outcomes of phase II oncology clinical trialsRasmus T Hoeg, Jennifer A Lee, Michelle A Mathiason, et al.
Pageof 41

Showing results (141-150 of 402) with videos related to

Sort By:
Pageof 41
Haematologica|October 19, 2019
Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasmsGaurav Goyal, Aishwarya Ravindran, Yuanhang Liu, et al.
British Journal of Haematology|November 20, 2008
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsJames N George, Susan D Mathias, Ronald S Go, et al.
American Journal of Hematology|January 13, 2022
A population-based study of acute panmyelosis with myelofibrosis in the United States: 2004-2015Nicole McLaughlin, Gordon Ruan, Courtney N Day, et al.
The American Journal of Surgical Pathology|January 6, 2026
Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic InfiltratesAlma R Oskarsdottir, Aishwarya Ravindran, Matthew J Koster, et al.
Journal of Hematology & Oncology|July 9, 2013
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)Daniel R Greenwald, Hailun Li, Selina M Luger, et al.
JCO Oncology Practice|October 23, 2020
Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely RecommendationsUrshila Durani, Dennis Asante, Herbert C Heien, et al.
British Journal of Haematology|March 14, 2018
Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United StatesPriyanka A Pophali, Adam Bartley, Prashant Kapoor, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 30, 2023
Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et alMatthew J Koster, Umar Ghaffar, Tanaz A Kermani, et al.
Rheumatology (Oxford, England)|May 25, 2023
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndromeAlexander S Hines, Matthew J Koster, Allison R Bock, et al.
American Journal of Clinical Oncology|April 8, 2009
Publication outcomes of phase II oncology clinical trialsRasmus T Hoeg, Jennifer A Lee, Michelle A Mathiason, et al.
Pageof 41